THOMAS JAMES DOYLE - 07 Feb 2022 Form 4 Insider Report for Kura Oncology, Inc. (KURA)

Role: SVP, Finance & Accounting
Signature: Teresa Bair, Attorney-in-fact for Thomas Doyle
Issuer symbol: KURA
Transactions as of: 07 Feb 2022
Net transactions value: $0
Form type: 4
Filing time: 09 Feb 2022, 16:50:35 UTC
Next filing: 31 Jan 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	KURA	Common Stock	Award	$0	+8,390	+127%	$0.000000	15,000	07 Feb 2022	Direct	F1
holding	KURA	Common Stock						500	07 Feb 2022	spouse's 401(k)

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	KURA	Option to purchase common stock	Award	$0	+39,281		$0.000000	39,281	07 Feb 2022	Common Stock	39,281	$13.14	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Grant of Restricted Stock Units (RSUs). The RSUs vest in four equal annual installments on 1/26/23, 1/26/24, 1/26/25 and 1/26/26.
F2	This option vests in 48 equal monthly installments commencing on the grant date.